Chemed to Share Business Updates and Strategy at BofA Securities 2026 Healthcare Conference
Chemed Corporation has announced its participation in the upcoming Bank of America Securities 2026 Health Care Conference, where the company is scheduled to present on Tuesday, May 12, 2026, at 3:00 PM Pacific Daylight Time. The event will take place at the Encore at the Wynn Las Vegas, a prominent venue known for hosting major industry conferences and corporate gatherings. This presentation represents an important opportunity for Chemed to engage with investors, analysts, and other stakeholders while highlighting its business performance, strategic priorities, and outlook for the future.
The company confirmed that its presentation will be accessible to a broader audience through a live webcast. Interested participants will be able to tune in via the Investor Relations section of Chemed’s official website. In addition to the live broadcast, Chemed will also provide presentation materials online, ensuring that viewers can follow along with key data, insights, and corporate updates shared during the session. For those unable to attend the live event, a replay of the webcast will be made available within 24 hours after the presentation concludes. This replay will remain accessible for a period of 90 days, offering flexibility for investors and interested parties to review the content at their convenience.
Chemed Corporation, headquartered in Cincinnati, Ohio, is a publicly traded company listed on the New York Stock Exchange under the ticker symbol CHE. The organization operates through two wholly owned subsidiaries, each of which serves a distinct market segment. These subsidiaries—VITAS Healthcare and Roto-Rooter—play a central role in Chemed’s overall business model and revenue generation.
VITAS Healthcare is widely recognized as the largest provider of end-of-life hospice care services in the United States. The organization focuses on delivering compassionate care to patients with life-limiting illnesses, supporting both patients and their families during critical moments. VITAS offers a comprehensive range of services, including pain management, symptom control, emotional and spiritual support, and assistance with daily living activities. Its interdisciplinary approach involves physicians, nurses, social workers, chaplains, and trained volunteers working collaboratively to ensure that patients receive personalized and dignified care. As the demand for hospice services continues to grow due to an aging population and increasing awareness of end-of-life care options, VITAS remains a key contributor to Chemed’s long-term growth strategy.
On the other hand, Roto-Rooter operates in an entirely different sector, providing plumbing, drain cleaning, and water cleanup services. As one of the leading service providers in this industry, Roto-Rooter has built a strong reputation for reliability, efficiency, and customer satisfaction. The company serves both residential and commercial clients, offering solutions for everything from routine maintenance to emergency plumbing repairs. Its nationwide presence and well-established brand make it a dominant player in the plumbing and drain cleaning market. By maintaining a strong focus on service quality and rapid response times, Roto-Rooter continues to generate steady revenue and contribute significantly to Chemed’s diversified business portfolio.
The dual-business structure of Chemed Corporation—spanning healthcare services and home maintenance solutions—provides a unique level of diversification that helps mitigate risk and stabilize earnings. While VITAS is influenced by healthcare policies, demographic trends, and regulatory changes, Roto-Rooter is more closely tied to housing markets, infrastructure needs, and consumer demand for maintenance services. This balance allows Chemed to navigate varying economic conditions more effectively than companies operating within a single industry.
During its presentation at the Bank of America Securities Health Care Conference, Chemed is expected to provide insights into its financial performance, operational highlights, and strategic initiatives. Investors will likely gain a deeper understanding of how the company is addressing industry challenges, capitalizing on growth opportunities, and positioning itself for long-term success. Topics may include expansion plans, technological advancements, workforce development, and efforts to enhance service delivery across both subsidiaries.
As with many publicly traded companies, Chemed includes forward-looking statements in its communications. These statements typically relate to anticipated future events, projected financial performance, and strategic plans. While such statements provide valuable insight into management’s expectations, they are inherently subject to risks and uncertainties. Factors such as changes in market conditions, regulatory developments, economic fluctuations, and unforeseen events can all impact actual results. As a result, investors are advised to approach forward-looking statements with caution and to consider them within the broader context of the company’s risk profile.
Chemed has emphasized that it does not undertake any obligation to update forward-looking statements in response to new information or changing circumstances. This is a standard practice among publicly traded companies, reflecting the dynamic nature of business environments and the difficulty of predicting future outcomes with absolute certainty.
Participation in high-profile conferences like the Bank of America Securities Health Care Conference is an important aspect of Chemed’s investor relations strategy. These events provide a platform for companies to communicate directly with the investment community, share updates on business operations, and reinforce transparency. For Chemed, the conference offers an opportunity to showcase the strengths of its two core businesses while addressing questions and concerns from analysts and investors.
The healthcare sector, in particular, remains a focal point for many investors due to its resilience and long-term growth potential. With an aging population and increasing demand for healthcare services, companies like Chemed—through its VITAS subsidiary—are well-positioned to benefit from these trends. At the same time, Roto-Rooter’s essential services ensure a steady stream of revenue, even during periods of economic uncertainty.
Overall, Chemed Corporation’s upcoming presentation is expected to provide valuable insights into the company’s operations, strategy, and outlook. By offering both a live webcast and an extended replay period, Chemed is ensuring broad accessibility and engagement with its stakeholders. As the company continues to operate across two distinct yet complementary industries, its ability to maintain strong performance and adapt to evolving market conditions will remain a key area of interest for investors and industry observers alike.
About
Statements in this press release or in other Chemed communications may relate to future events or Chemed’s future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
